Has Graham Long, MD received payments from drug or device companies?

Yes. Drug and device makers reported $21,868 in general payments to Graham Long, MD across 169 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Graham Long, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Graham Long, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Graham Long, MD

Vascular Surgery · Troy, MINPI 1932179132

Payments from drug & device makers

What this record shows

This record is dominated by other: $14,014 of the $21,868 with a category attached, or 64.1%. Angiodynamics, Inc. accounts for 64.3% of it on its own, with 46 other manufacturers making up the rest. 2025 is the largest year on record at $14,300, more than ten times the $1,152 reported in 2019.

$21,868in general payments, 2019–2025

Across 169 payments — averaging $129.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Angiodynamics, Inc.$14K
Boston Scientific$1K
Silk Road Medical, Inc.$696
W. L. Gore & Associates, Inc.$692
Medtronic$666
Integra Lifesciences Corporation$517
plus $4K from 41 others

$71,570in research payments, 2019–2025

Across 41 payments — averaging $1745.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Cook Research Incorporated$33K
Veryan Medical Incorporated$20K
Inari Medical, Inc.$19K

What the payments were for

Travel & lodging$1,6608%
Food & beverage$6,19328%
Other$14,01464%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Angiodynamics, Inc.	4	$14,056
Boston Scientific	12	$1,487
Silk Road Medical, Inc.	6	$696
W. L. Gore & Associates, Inc.	8	$692
Medtronic(2 entities)	17	$666
Integra Lifesciences Corporation	10	$517
Bard Peripheral Vascular, Inc.	9	$315
Lemaitre Vascular, Inc.	3	$308
Endologix LLC	5	$305
Johnson & Johnson(2 entities)	10	$228
Inari Medical, Inc.	2	$197
Kerecis Limited	4	$189
Penumbra, Inc.	5	$175
Medela LLC	1	$163
Mimedx Group, Inc.	2	$144
Cardiva Medical, Inc.	4	$140
Philips North America LLC	6	$135
Bolton Medical Inc	3	$130
Pfizer	6	$128
Tactile Systems Technology Inc	6	$122
Shockwave Medical, Inc	3	$106
Terumo Medical Corporation	1	$89
Smith+Nephew	5	$81
Cook Medical LLC	5	$80
Getinge USA Sales, LLC	2	$71
Imperative Care, Inc	1	$67
Acera Surgical, Inc.	3	$58
Surmodics, Inc.	2	$50
Cordis US CORP.	2	$38
Cardiovascular Systems Inc.	3	$37
Aroa Biosurgery Incorporated	1	$36
Teleflex LLC	2	$36
My01 Inc.	1	$33
Avenu Medical Inc.	2	$31
Surgenex LLC	1	$27
Polynovo North America LLC	1	$26
Bioventus LLC	1	$26
Lifenet Health	1	$26
Convatec Inc.	1	$24
Atricure, Inc.	1	$23
Avinger Inc.	1	$21
Siemens Medical Solutions USA, Inc.	1	$18
Sanara Medtech Inc.	1	$16
Acell, Inc.	1	$15
E.r. Squibb & Sons, L.L.C.	1	$14
Neuros Medical, Inc.	1	$14
Abbott	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$21,868 in reported general payments places this provider in the 85th percentile of 183 vascular surgery providers in Michigan.

See all vascular surgery providers in Michigan →

Medicare billing

Part B allowed, 2024

$303,787

Medicare patients

1,127

Services billed

2,216

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	72	$1,279
Rosuvastatin Calcium	16	$311
Atorvastatin Calcium	27	$165
Prednisone	18	$18

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Troy

Maciej UziebloTroy$36K
Nicolas MouawadWest Branch$1.7M
Enrique Criado PallaresMidland$800K
Jordan KnepperEast Lansing$336K
Joseph CuppariClinton Township$98K
Eanas YassaGrand Rapids$81K
Abedelkarim AbushmaiesBattle Creek$75K
Kevin OnofreyDetroit$65K
Yevgeniy RitsDetroit$57K
Ryan KimSaginaw$50K

See the full list for Michigan →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →